Trial of Vemurafenib/Cobimetinib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- F. Stephen Hodi, MD
Dana-Farber Cancer Institute
Principal Investigator - Michael B Atkins, MD
Beth Israel Deaconess Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Angeles Clinic
Los Angeles, California, United States
- University of Colorado Cancer Center
Aurora, Colorado, United States
- Georgetown Lombardi Comprehensive Cancer Center
Washington D.C., District of Columbia, United States
- Washington Cancer Institute at Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- Harry and Jeannette Weinberg Cancer Institute at Franklin Square
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center (bidmc)
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Columbia University Medical Center
New York, New York, United States
- Nyu Clinical Cancer Center
New York, New York, United States
- Osu Comprehensive Cancer Center
Columbus, Ohio, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
- University of Washington Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2013
- Primary completion
- 31 Jan 2016
- Completion
- 30 Jun 2016
- Last update posted
- 24 Oct 2017
- Registered enrollment
- 10
- Registry id
- NCT01495988
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.